Legal & General Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Sell |
93,645
-3,291
| -3% | -$41.9K | ﹤0.01% | 2086 |
|
|
2025
Q4 | $871K | Sell |
96,936
-10,063
| -9% | -$139K | ﹤0.01% | 2259 |
|
|
2025
Q3 | $1.85M | Sell |
106,999
-460
| -0.4% | -$5.67K | ﹤0.01% | 2016 |
|
|
2025
Q2 | $1.01M | Buy |
107,459
+3,591
| +3% | +$29.5K | ﹤0.01% | 2237 |
|
|
2025
Q1 | $739K | Sell |
103,868
-2,899
| -3% | -$29.3K | ﹤0.01% | 2281 |
|
|
2024
Q4 | $1.24M | Buy |
106,767
+17,549
| +20% | +$274K | ﹤0.01% | 2169 |
|
|
2024
Q3 | $1.83M | Buy |
89,218
+1,660
| +2% | +$38.3K | ﹤0.01% | 2016 |
|
|
2024
Q2 | $1.96M | Buy |
87,558
+1,001
| +1% | +$23.8K | ﹤0.01% | 1952 |
|
|
2024
Q1 | $2.38M | Buy |
86,557
+5,814
| +7% | +$161K | ﹤0.01% | 1865 |
|
|
2023
Q4 | $2.46M | Buy |
80,743
+596
| +0.7% | +$17.1K | ﹤0.01% | 1849 |
|
|
2023
Q3 | $2.53M | Buy |
80,147
+4,752
| +6% | +$184K | ﹤0.01% | 1794 |
|
|
2023
Q2 | $3.07M | Buy |
75,395
+1,279
| +2% | +$51.9K | ﹤0.01% | 1715 |
|
|
2023
Q1 | $2.76M | Buy |
74,116
+1,699
| +2% | +$66.6K | ﹤0.01% | 1731 |
|
|
2022
Q4 | $2.53M | Buy |
72,417
+3,893
| +6% | +$185K | ﹤0.01% | 1768 |
|
|
2022
Q3 | $3.83M | Sell |
68,524
-4,032
| -6% | -$250K | ﹤0.01% | 1503 |
|
|
2022
Q2 | $3.76M | Buy |
72,556
+5,105
| +8% | +$259K | ﹤0.01% | 1562 |
|
|
2022
Q1 | $4.9M | Buy |
67,451
+2,503
| +4% | +$212K | ﹤0.01% | 1524 |
|
|
2021
Q4 | $7.68M | Buy |
64,948
+7,930
| +14% | +$993K | ﹤0.01% | 1346 |
|
|
2021
Q3 | $7.65M | Buy |
57,018
+14,569
| +34% | +$2.21M | ﹤0.01% | 1317 |
|
|
2021
Q2 | $6.87M | Buy |
42,449
+5,002
| +13% | +$389K | ﹤0.01% | 1375 |
|
|
2021
Q1 | $3.01M | Sell |
37,447
-27,969
| -43% | -$1.88M | ﹤0.01% | 1805 |
|
|
2020
Q4 | $3.56M | Sell |
65,416
-28,133
| -30% | -$1.02M | ﹤0.01% | 1644 |
|
|
2020
Q3 | $1.86M | Buy |
93,549
+35,020
| +60% | +$730K | ﹤0.01% | 1787 |
|
|
2020
Q2 | $1.23M | Buy |
58,529
+37,975
| +185% | +$645K | ﹤0.01% | 1917 |
|
|
2020
Q1 | $286K | Buy |
20,554
+9,078
| +79% | +$122K | ﹤0.01% | 2199 |
|
|
2019
Q4 | $168K | Buy |
11,476
+1,326
| +13% | +$18.4K | ﹤0.01% | 2438 |
|
|
2019
Q3 | $131K | Buy |
10,150
+2,243
| +28% | +$35.8K | ﹤0.01% | 2451 |
|
|
2019
Q2 | $121K | Buy |
7,907
+2,043
| +35% | +$32.1K | ﹤0.01% | 2470 |
|
|
2019
Q1 | $100K | Hold |
5,864
| – | – | ﹤0.01% | 2485 |
|
|
2018
Q4 | $80K | Buy |
5,864
+437
| +8% | +$8.12K | ﹤0.01% | 2519 |
|
|
2018
Q3 | $156K | Hold |
5,427
| – | – | ﹤0.01% | 2389 |
|
|
2018
Q2 | $149K | Buy |
5,427
+2,333
| +75% | +$56.5K | ﹤0.01% | 2366 |
|
|
2018
Q1 | $65K | Sell |
3,094
-1,385
| -31% | -$34.1K | ﹤0.01% | 2630 |
|
|
2017
Q4 | $87K | Buy |
4,479
+248
| +6% | +$5.72K | ﹤0.01% | 2651 |
|
|
2017
Q3 | $104K | Buy |
4,231
+599
| +16% | +$11.3K | ﹤0.01% | 2625 |
|
|
2017
Q2 | $58K | Buy |
3,632
+1,241
| +52% | +$17.3K | ﹤0.01% | 2876 |
|
|
2017
Q1 | $33K | Buy |
2,391
+190
| +9% | +$2.55K | ﹤0.01% | 2952 |
|
|
2016
Q4 | $29K | Buy |
2,201
+640
| +41% | +$9.62K | ﹤0.01% | 3041 |
|
|
2016
Q3 | $26K | Hold |
1,561
| – | – | ﹤0.01% | 2773 |
|
|
2016
Q2 | $35K | Buy |
+1,561
| New | +$41.5K | ﹤0.01% | 2654 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
